Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer, Mike Kaswan, MBA, To Management Team

Cognoptix, a leading diagnostics company dedicated to the early detection of Alzheimer’s disease (AD), announces two appointments to its senior management team. Dr. Carl H. Sadowsky, MD will serve as the company’s new Chief Medical Officer (CMO) and Mike Kaswan, MBA will be Cognoptix’s Chief Financial Officer (CFO). Read more >>

Congress Extends Student Loan Repayment Provision to 2025

Employers will be allowed to make tax-free contributions of up to $5,250 per employee annually toward eligible education expenses, including tuition or student loan assistance. The passage this week of the stimulus bill approved by Congress preserves the tax-free status of employer payments toward employee student loans through 2025, a marked difference from the year-end expiration date included in the Coronavirus Aid, Relief and Economic Security (CARES) Act…

The CARES Act’s semi-permanent status meant fewer employers were willing […]

Cognoptix Announces Formation of a New Board of Directors

Cognoptix is a breakthrough diagnostics company developing an innovative office-based device-drug system for the early detection of Alzheimer’s disease (AD). As another milestone of the Series R restart, recapitalization, and revitalization, the company named a new Board of Directors (BOD) formed under the leadership of Dr. Susanne Wilke, Ph.D., Cognoptix’ new President and CEO. Read more >>

Here are the top angel groups between the coasts

The economic upheaval caused by the Covid-19 pandemic has created a once-in-a-generation surge of startups across the U.S. According to government data and a Goldman Sachs report, the share of Americans starting new businesses has risen sharply in 2020.

Boston Harbor Angels on the list of top angel groups. Read more >>

Groton Connecticut based Astrocyte Pharmaceuticals is raising $8,655,148.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Astrocyte Pharmaceuticals is raising $8,655,148.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, William Korinek played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development. Read more >>

ZetrOZ Systems’ Wearable Ultrasound Device, SAM, Receives Expanded FDA Re-Approval, Positioning the Company for Market Growth in 2021

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, is the global leader in development of SAM technologies. With its reapproval for expanded use in 2020, the use of SAM ultrasound technology in both professional and at-home applications is expected to increase market growth significantly over the next several years. Read more >>